Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1262523-70-5

Post Buying Request

1262523-70-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1262523-70-5 Usage

Chemical compound

1262523-70-5

Type

Synthetic organic compound

Function

Potent and selective inhibitor of the PARP enzyme

Involvement

DNA repair and maintenance

Therapeutic applications

Being studied for potential use in cancer treatment

Preclinical studies

Shown promising results

Research focus

Enhancing efficacy of traditional cancer treatments (chemotherapy and radiotherapy)

Potential implications

Other disease areas, such as neurodegenerative disorders and inflammatory diseases

Further research

Clinical trials and additional studies needed to understand full potential as a therapeutic agent.

Check Digit Verification of cas no

The CAS Registry Mumber 1262523-70-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,2,5,2 and 3 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1262523-70:
(9*1)+(8*2)+(7*6)+(6*2)+(5*5)+(4*2)+(3*3)+(2*7)+(1*0)=135
135 % 10 = 5
So 1262523-70-5 is a valid CAS Registry Number.

1262523-70-5Downstream Products

1262523-70-5Relevant articles and documents

Synthesis of optically pure 4-fluoro-glutamines as potential metabolic imaging agents for tumors

Qu, Wenchao,Zha, Zhihao,Ploessl, Karl,Lieberman, Brian P.,Zhu, Lin,Wise, David R.,Thompson, Craig B.,Kung, Hank F.

, p. 1122 - 1133 (2011/04/16)

A versatile synthetic route to prepare all four stereoisomeric 4-fluoro-glutamines was developed by exploiting a Passerini three-component reaction. The skeleton of 4-substituted glutamine derivatives was efficiently constructed. Subsequent four-step reactions, highlighted by a "neutralized" TASF fluorination, provided the desired products with high yields and excellent optical purity. The optically pure fluorine-18 labeled 4-fluoroglutamines were also successfully prepared using either a 18-crown-6/KHCO3 or K[222]/K2CO3 catalysis system. Preliminary cell uptake and inhibition studies using the 9L tumor cells ana SF188BC1-XL tumor cells (a glutamine addicted tumor derived from glioblastoma) provided strong evidence for their potential application in conjunction with positron emission tomography (PET) for in vivo imaging of tumors, which use glutamine as an alternative energy source.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1262523-70-5